VRTX - Vertex Pharmaceuticals Inc / Ma - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - VRTX (875320)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-02-18
VRTXTatsis OuraniaSVP, CROS - Sale$243.62-1,27915,070-8%-$311,585
2020-02-18
VRTXSilva Paul MSVP, ControllerS - Sale$243.58-1,56417,045-8%-$380,957
2020-02-18
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale$243.56-3,48956,519-6%-$849,780
2020-02-18
VRTXParini MichaelEVP, CL, AOS - Sale$243.61-3,12832,282-9%-$762,020
2020-02-18
VRTXLeiden Jeffrey MCEO, PresS - Sale$243.52-11,685111,981-9%-$2,845,518
2020-02-18
VRTXKewalramani ReshmaEVP, CMOS - Sale$243.51-1,18333,158-3%-$288,070
2020-02-18
VRTXArbuckle Stuart AEVP, Chief Commercial OfficerS - Sale$243.56-3,12841,851-7%-$761,842
2020-02-18
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$243.67-3,12834,346-8%-$762,201
2020-02-11
VRTXSilva Paul MSVP, ControllerS - Sale$246.04-5,86219,857-23%-$1,442,301
2020-02-11
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale$246.08-13,07063,270-17%-$3,216,311
2020-02-11
VRTXParini MichaelEVP, CL, AOS - Sale$246.11-16,88237,906-31%-$4,154,832
2020-02-11
VRTXLeiden Jeffrey MCEO, PresS - Sale$246.09-47,523132,980-26%-$11,694,933
D
2020-02-10
VRTXLee YuchunDirS - Sale+OE$242.51-1,1811,875-39%-$286,403
2020-02-11
VRTXArbuckle Stuart AEVP, Chief Commercial OfficerS - Sale$246.09-11,28647,475-19%-$2,777,325
2020-02-11
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$246.11-17,03239,970-30%-$4,191,771
D
2020-02-07
VRTXLee YuchunDirS - Sale+OE$237.82-2,0001,875-52%-$475,643
D
2020-02-06
VRTXLee YuchunDirS - Sale+OE$239.51-2,0001,875-52%-$479,017
D
2020-02-06
VRTXTatsis OuraniaSVP, CROS - Sale+OE$239.43-96716,946-5%-$231,527
D
2020-02-06
VRTXSilva Paul MSVP, ControllerS - Sale+OE$239.32-46630,392-2%-$111,523
D
2020-02-06
VRTXParini MichaelEVP, CL, AOS - Sale+OE$239.42-2,52668,246-4%-$604,783
D
2020-02-06
VRTXKewalramani ReshmaEVP, CMOS - Sale+OE$239.44-2,07435,285-6%-$496,600
D
2020-02-06
VRTXArbuckle Stuart AEVP, Chief Commercial OfficerS - Sale+OE$239.42-2,78767,703-4%-$667,253
D
2020-02-06
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$239.42-2,52670,310-3%-$604,775
DM
2020-02-04
VRTXLee YuchunDirS - Sale+OE$240.61-4,0001,875-68%-$962,434
D
2020-02-03
VRTXSilva Paul MSVP, ControllerS - Sale+OE$231.03-2,09917,928-10%-$484,939
D
2020-02-03
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$231.11-4,09753,262-7%-$946,845
D
2020-02-03
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$231.18-4,12631,553-12%-$953,861
D
2020-01-31
VRTXSilva Paul MSVP, ControllerS - Sale+OE$238.65-1,39617,928-7%-$333,155
D
2020-01-31
VRTXSachs Bruce IDirS - Sale+OE$227.99-20,00011,210-64%-$4,559,830
DM
2020-01-31
VRTXParini MichaelEVP, CL, AOS - Sale+OE$234.66-8,34531,553-21%-$1,958,233
M
2020-01-31
VRTXLee YuchunDirS - Sale$229.56-4,000847-83%-$918,237
DM
2020-01-31
VRTXArbuckle Stuart AEVP, Chief Commercial OfficerS - Sale+OE$235.33-8,40233,380-20%-$1,977,211
D
2020-01-22
VRTXParini MichaelEVP, CL, AOS - Sale+OE$237.50-135,0030%-$238
D
2020-01-16
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$235.00-5,00053,262-9%-$1,175,000
D
2020-01-13
VRTXSilva Paul MSVP, ControllerS - Sale+OE$229.38-86017,928-5%-$197,267
D
2020-01-13
VRTXParini MichaelEVP, CL, AOS - Sale+OE$226.78-2,12535,003-6%-$481,911
D
2020-01-08
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$230.00-5,00053,262-9%-$1,150,000
D
2020-01-08
VRTXSilva Paul MSVP, ControllerS - Sale+OE$231.89-13,75017,928-43%-$3,188,488
D
2020-01-08
VRTXTatsis OuraniaSVP, CROS - Sale+OE$227.53-1,6757,252-19%-$381,113
D
2020-01-06
VRTXParini MichaelEVP, CL, AOS - Sale+OE$222.00-4,25035,003-11%-$943,514
D
2020-01-02
VRTXYoung William DDirS - Sale+OE$218.94-20,0009,311-68%-$4,378,696
D
2020-01-02
VRTXSilva Paul MSVP, ControllerS - Sale+OE$218.92-25,63017,928-59%-$5,610,993
D
2019-12-30
VRTXYoung William DDirS - Sale+OE$218.76-30,0009,311-76%-$6,562,715
D
2019-12-09
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$225.00-5,00053,262-9%-$1,125,000
D
2019-11-25
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$220.00-5,00053,262-9%-$1,100,000
D
2019-11-25
VRTXKewalramani ReshmaEVP, CMOS - Sale+OE$219.37-4,69213,098-26%-$1,029,284
D
2019-11-25
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$219.37-3,91031,553-11%-$857,737
D
2019-11-19
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$210.91-96,534106,786-47%-$20,360,052
D
2019-11-19
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$215.00-5,00053,262-9%-$1,075,000
2019-11-15
VRTXTatsis OuraniaSVP, CROS - Sale$205.95-57,2520%-$1,030
2019-11-15
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale$205.95-5753,2620%-$11,739
2019-11-15
VRTXParini MichaelEVP, CL, AOS - Sale$205.95-8435,0030%-$17,300
DM
2019-11-15
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$210.00-9,434106,786-8%-$1,981,140
2019-11-15
VRTXKewalramani ReshmaEVP, CMOS - Sale$205.95-6113,0980%-$12,563
2019-11-15
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale$205.95-1933,3800%-$3,913
2019-11-15
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$205.95-6031,5530%-$12,357
D
2019-11-13
VRTXTatsis OuraniaSVP, CROS - Sale+OE$205.59-2,8537,252-28%-$586,548
D
2019-11-13
VRTXParini MichaelEVP, CL, AOS - Sale+OE$205.50-4,89235,003-12%-$1,005,306
D
2019-11-13
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$205.57-8,56033,380-20%-$1,759,679
D
2019-11-08
VRTXKewalramani ReshmaEVP, CMOS - Sale+OE$199.00-50913,098-4%-$101,291
D
2019-11-06
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$197.21-1,22331,553-4%-$241,189
D
2019-11-04
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$200.34-4,09753,262-7%-$820,795
D
2019-11-04
VRTXParini MichaelEVP, CL, AOS - Sale+OE$200.50-2,33035,003-6%-$467,168
D
2019-11-04
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$201.62-3,70833,380-10%-$747,607
D
2019-11-04
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$200.45-4,12631,553-12%-$827,049
DM
2019-10-31
VRTXKearney Terrence CDirS - Sale+OE$200.00-52,4485,811-90%-$10,489,600
DM
2019-10-31
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$200.01-105,701106,727-50%-$21,141,792
D
2019-11-01
VRTXBhatia Sangeeta N.DirS - Sale+OE$200.00-1,2915,249-20%-$258,200
D
2019-10-30
VRTXKewalramani ReshmaEVP, CMOS - Sale+OE$199.00-3,05713,098-19%-$608,343
D
2019-10-25
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$195.01-4,31153,262-7%-$840,688
D
2019-10-22
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$190.27-3,88353,262-7%-$738,818
D
2019-10-22
VRTXMcGlynn Margaret GDirS - Sale+OE$190.00-20,0004,124-83%-$3,800,000
D
2019-10-22
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$190.00-107,831106,727-50%-$20,487,890
2019-10-22
VRTXKewalramani ReshmaEVP, CMOS - Sale$189.00-63813,098-5%-$120,582
D
2019-10-22
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$194.37-3,66931,553-10%-$713,144
D
2019-10-17
VRTXParini MichaelEVP, CL, AOS - Sale+OE$177.80-4,25035,003-11%-$755,650
D
2019-10-14
VRTXParini MichaelEVP, CL, AOS - Sale+OE$174.06-2,12535,003-6%-$369,885
D
2019-10-02
VRTXBhatia Sangeeta N.DirS - Sale+OE$166.80-8,3795,249-61%-$1,397,640
M
2019-10-01
VRTXTatsis OuraniaSVP, CROS - Sale$168.11-6327,252-8%-$106,247
D
2019-08-19
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$186.38-12,50131,553-28%-$2,329,976
D
2019-08-13
VRTXMcGlynn Margaret GDirS - Sale+OE$185.00-10,0004,124-71%-$1,850,000
D
2019-08-08
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$181.89-2,12533,380-6%-$386,516
D
2019-08-05
VRTXParini MichaelEVP, CL, AOS - Sale+OE$175.28-2,33035,003-6%-$408,399
DM
2019-08-02
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$177.22-3,70832,380-10%-$657,127
D
2019-07-12
VRTXParini MichaelEVP, CL, AOS - Sale+OE$175.27-2,12535,003-6%-$372,455
D
2019-07-05
VRTXParini MichaelEVP, CL, AOS - Sale+OE$179.12-4,25035,003-11%-$761,239
D
2019-06-19
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$181.89-2,12533,380-6%-$386,516
D
2019-06-18
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$175.39-56,030106,727-34%-$9,827,054
2019-06-03
VRTXBhatia Sangeeta N.DirS - Sale$167.08-7206,540-10%-$120,298
D
2019-05-24
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$175.10-113,432106,727-52%-$19,861,943
2019-05-15
VRTXSachdev AmitEVP, CROS - Sale$165.41-6153,2620%-$10,090
2019-05-15
VRTXSilva Paul MSVP, ControllerS - Sale$165.41-16117,928-1%-$26,631
2019-05-15
VRTXParini MichaelEVP, CL, AOS - Sale$165.41-8335,0030%-$13,729
2019-05-15
VRTXKewalramani ReshmaEVP, CMOS - Sale$165.41-24113,736-2%-$39,864
2019-05-15
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale$165.41-13333,3800%-$22,000
2019-05-15
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$165.41-9131,5530%-$15,052
D
2019-05-06
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$175.01-33,058215,130-13%-$5,785,504
DM
2019-05-03
VRTXParini MichaelEVP, CL, AOS - Sale+OE$172.34-2,32971,835-3%-$401,385
DM
2019-05-02
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$170.57-3,70867,933-5%-$632,491
D
2019-05-01
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$175.08-10,480106,635-9%-$1,834,826
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top